Bio-Gene Technology Limited

Equities

BGT

AU000000BGT8

Agricultural Chemicals

Market Closed - Australian S.E. 09:07:12 2024-05-16 pm EDT 5-day change 1st Jan Change
0.061 AUD 0.00% Intraday chart for Bio-Gene Technology Limited +1.67% +1.67%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023 MT
Bio-Gene Technology Limited Approves the Election of Alex Ding as Director CI
Bio-Gene Technology Limited Announces Resignation of Rodrigo Valencia as Joint CFO CI
Bio-Gene Technology Limited Announces the Resignation of Rodrigo Valencia as Company Secretary CI
Bio-Gene Technology Limited Announces the Appointment of Roger Mcpherson as Joint Company Secretary CI
Bio-Gene Technology Raises Further Funds Under Placement, SPP; Shares Slip 3% MT
Bio-Gene Technology to Raise AUD 2.5 Million CI
Bio-Gene Technology Limited Appoints Owen Timothy Grogan as Director CI
Bio-gene Technology Secures US Patent for Insecticide Product MT
Bio-Gene Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Bio-Gene Technology Limited Announces Managing Director Changes CI
Bio-Gene Technology Limited Announces Chief Executive Officer Changes CI
Bio-Gene Technology Limited Appoints Alex Huong Soo Ding as Director CI
Bio-Gene Technology Limited Appoints Christopher Mark Ramsey as Director CI
Bio-Gene Technology Limited Announces Changes to the Board CI
Altor Capital Management Pty Ltd Withdraws its Notices CI
Government Research Entity Supports Commercialization of Bio-Gene Technology's Insecticide; Shares Soar 21% MT
Bio-Gene Technology Limited Announces Extension of the Licence and Development Agreement with Clarke for the United States and Cayman Islands CI
Bio-Gene Technology Limited Appoints Rod Valencia as CFO and Company Secretary CI
Bio-Gene Signs Binding Term Sheet with STK on Global Collaboration to Develop, Register and Commercialise Qcide for Crop Protection Applications CI
Bio-Gene Technology Limited Receives Notice from T & L Ainsworth Investments Pty Ltd CI
Bio-Gene Technology CEO to Transition Into Consultancy, Advisory Role MT
Bio-Gene Technology Limited Announces Board Changes CI
Expectations of Further US Fed Rate Hikes Bear Down on Australian Shares MT
Chart Bio-Gene Technology Limited
More charts
Bio-Gene Technology Limited is an Australia-based agriculture technology development company. The Company’s principal activity is to develop and commercialize insecticides/pesticides. Its platform technology is based on a naturally occurring class of chemicals known as beta-triketones, that seeks to address the global problems of insecticide resistance and toxicity. The Company's lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a chemically synthesized product based on flavesone. Qcide is a natural oil product containing tasmanone as the active constituent. The oil is extracted from the leaves of the Gympie Messmate, by utilizing a steam distillation process. Its platform provides multiple solutions for insecticide manufacturers in applications across crop protection and storage, public health, animal health and consumer applications. The Company also aims to develop and commercialize a portfolio of targeted insect control and management solutions.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BGT Stock
  4. News Bio-Gene Technology Limited
  5. Bio-Gene Technology CEO to Transition Into Consultancy, Advisory Role
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW